CVE-2025-3423

Name: CVE-2025-3423
Creator: NVD / NIST
Published: 2025-04-13T12:15:14.463+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 5.4/10EPSS 0.22%

Last modified Jun 17, 2026

CVE-2025-3423 is a medium-severity vulnerability rated 5.4/10 on the CVSS scale. IBM Aspera Faspex 5.0.0 through 5.0.11 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.. EPSS estimates a 0.22% chance of exploitation in the next 30 days.

Description

IBM Aspera Faspex 5.0.0 through 5.0.11 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Metrics

CVSS 3.1

5.4/10

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

EPSS Probability

0.22%

12.5th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-79

Affected Software

Vendor	Product	Versions
Ibm	Aspera Faspex	>= 5.0.0, < 5.0.12

References

https://www.ibm.com/support/pages/node/7230757Vendor Advisory

Timeline

Published: Apr 13, 2025
Last Modified: Jun 17, 2026
Status: Analyzed

Frequently Asked Questions

What is CVE-2025-3423?

How severe is CVE-2025-3423?

CVE-2025-3423 has a CVSS score of 5.4/10 (MEDIUM severity). The EPSS model estimates a 0.22% probability of exploitation in the next 30 days.

How do I fix CVE-2025-3423?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2025-3423?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST